Form 4: Perspective Therapeutics Director Lori A. Woods Increases Stake
SEC Form 4 Filing
Director Lori A. Woods reports acquisition of 34,246 shares of Perspective Therapeutics (CATX) at $1.4598 per share.
Summary
- On June 3, 2024, Lori A. Woods, a director of Perspective Therapeutics, Inc. (CATX), acquired 34,246 shares of common stock at a price of $1.4598 per share.
- The shares were acquired indirectly through the Woods Family Living Trust.
- Following the transaction, Woods beneficially owns 1,553,984 shares through the trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders. It provides transparency into the trading activities of individuals with access to non-public information.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of transaction: Lori A. Woods acquired shares of common stock. |
| 06/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.